Back to Webinars
Efficacy of Polyfunctional GD3 CAR T Cells against Rare Tumors

Featured Speaker: Caroline Le Poole, PhD, Professor of Dermatology and Microbiology-Immunology at Northwestern University Feinberg School of Medicine

Your data is secure. We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from Bruker Cellular Analysis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this Webinar we discuss:

Review published data showing how polyfunctional GD3 CAR T cells created to target the TSC tumor immunogens can substantially reduce tumor burden in a mouse model.

Learn how IsoPlexis' single-cell multiplex cytokine profiling uncovered rare polyfunctional CAR T cell subsets indicating the functional capacity for improved anti-tumor response.

Watch the Q&A session with our expert panelist.

Watch the Webinar